EGFR and breast cancer: However, a ligand-independent mechanism was also demonstrated for AXL activation either by reactive oxygen species [47, 48], by homodimerization upon AXL overexpression [49, 50], or by heterodimerization with EGFR (epidermal growth factor receptor) as was shown in a breast cancer model [8].